Shockwave therapy shows promise for relieving neurodermatitis itch
NCT ID NCT07206680
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether extracorporeal shockwave therapy (ESWT) can reduce itching in people with neurodermatitis. Thirty-four adults aged 55 to 75 received four weekly sessions of shockwaves applied to the skin. The main goal was to measure changes in itch severity using a standard scale. The results could point to a new, drug-free option for managing this uncomfortable condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Shockwave therapy (a device that delivers sound waves to the skin)
- What this could lead to
- If it works, this could offer a new, non-drug way to ease severe itching in people with neurodermatitis.
- What could go wrong
- This is a small, early-stage study with only 34 participants and no comparison group, so results may not apply broadly. The treatment is short-term and effects may not last.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
34 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
55 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age range between 55:75 years. * Male and female patients will participate in the study. * All patients have neurodermatitis. * All patients will be received the same approach of medication and nursing care. * All patients enrolled in the study will have their informed consent. Exclusion Criteria: * Patients diagnosed with cancer. * Pregnant woman. * active infection. * Patients with any systemic diseases that may interfere with the objectives of the study. * Cardiac pacemakers or other implantable devices. * Current anticoagulation use. * Any other cause of itching
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neurodermatitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Suez Canal University Hospital
Ismailia, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.